{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:56:10Z","timestamp":1792403770037,"version":"4.4.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.msard.2025.106309","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T20:15:41Z","timestamp":1738959341000},"page":"106309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Cerebrospinal fluid interferon-\u03b3 and development of depression in multiple sclerosis"],"prefix":"10.1016","volume":"95","author":[{"given":"Giulia","family":"Menculini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Sperandei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Gaetani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianmarco","family":"Cinesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Di Sabatino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bellingacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Canonichesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisella","family":"Guerrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Battistini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Tortorella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucilla","family":"Parnetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Borsellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2645-7477","authenticated-orcid":false,"given":"Massimiliano","family":"Di Filippo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2025.106309_bib0036","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4081\/ni.2017.7343","article-title":"Depression and anxiety as determinants of health-related quality of life in patients with multiple sclerosis - United Arab Emirates","volume":"9","author":"Alsaadi","year":"2017","journal-title":"Neurol. Int."},{"key":"10.1016\/j.msard.2025.106309_bib0052","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12529-022-10078-6","article-title":"The mediating role of stigma, internalized shame, and autonomous motivation in the relationship between depression, Anxiety, and psychological help-seeking attitudes in multiple sclerosis","volume":"30","author":"Barta","year":"2023","journal-title":"Int. J. Behav. Med."},{"key":"10.1016\/j.msard.2025.106309_bib0020","series-title":"Beck Depression Inventory\u2013II (BDI\u2013II)","author":"Beck","year":"1996"},{"key":"10.1016\/j.msard.2025.106309_bib0039","doi-asserted-by":"crossref","first-page":"e2216","DOI":"10.1212\/WNL.0000000000008617","article-title":"Disability worsening among persons with multiple sclerosis and depression: a Swedish cohort study","volume":"93","author":"Binzer","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106309_bib0031","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jns.2016.11.067","article-title":"Prevalence of depression and anxiety in Multiple Sclerosis: a systematic review and meta-analysis","volume":"372","author":"Boeschoten","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2025.106309_bib0013","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.psyneuen.2018.01.002","article-title":"Depression and fatigue in multiple sclerosis: relation to exposure to violence and cerebrospinal fluid immunomarkers","volume":"89","author":"Brenner","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.msard.2025.106309_bib0051","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neulet.2014.06.039","article-title":"Further evidence for the role of interferon-gamma on anxiety- and depressive-like behaviors: involvement of hippocampal neurogenesis and NGF production","volume":"578","author":"Campos","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.msard.2025.106309_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102042","article-title":"Anxiety in Argentinian patients with multiple sclerosis: prevalence and associated factors","volume":"41","author":"Chertcoff","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106309_bib0050","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.euroneuro.2005.11.011","article-title":"Antidepressants suppress production of the Th1 cytokine interferon-gamma, independent of monoamine transporter blockade","volume":"16","author":"Diamond","year":"2006","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.msard.2025.106309_bib0041","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1212\/01.WNL.0000110316.12086.0C","article-title":"Structural brain abnormalities in multiple sclerosis patients with major depression","volume":"62","author":"Feinstein","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106309_bib0042","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/1352458509355461","article-title":"Diffusion tensor imaging abnormalities in depressed multiple sclerosis patients","volume":"16","author":"Feinstein","year":"2010","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106309_bib0029","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1007\/s10072-013-1485-7","article-title":"Guidelines from The Italian Neurological and Neuroradiological Societies for the use of magnetic resonance imaging in daily life clinical practice of multiple sclerosis patients","volume":"34","author":"Filippi","year":"2013","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.msard.2025.106309_bib0001","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","article-title":"Multiple sclerosis","volume":"4","author":"Filippi","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.msard.2025.106309_bib0030","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.1002\/hbm.26424","article-title":"BIANCA-MS: an optimized tool for automated multiple sclerosis lesion segmentation","volume":"44","author":"Gentile","year":"2023","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.msard.2025.106309_bib0038","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1176\/appi.neuropsych.18010011","article-title":"Depressive symptoms are associated with more negative functional outcomes than anxiety symptoms in persons with multiple sclerosis","volume":"31","author":"Gill","year":"2019","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.msard.2025.106309_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102261","article-title":"Anxiety and depression in Multiple Sclerosis (MS): antecedents, consequences, and differential impact on well-being and quality of life","volume":"44","author":"Hanna","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106309_bib0027","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1365-2648.1998.00764.x","article-title":"Fear of patients related to coronary arteriography","volume":"28","author":"Heikkil\u00e4","year":"1998","journal-title":"J. Adv. Nurs."},{"key":"10.1016\/j.msard.2025.106309_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105866","article-title":"Evidence of symptom specificity for depression in multiple sclerosis: a two sample Mendelian randomization study","volume":"91","author":"Hu","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106309_bib0046","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1007\/s12035-018-1359-3","article-title":"Neuroimmunomodulation in major depressive disorder: focus on caspase 1, inducible nitric oxide synthase, and interferon-gamma","volume":"56","author":"Inserra","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.msard.2025.106309_bib0040","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1034\/j.1600-0404.2003.00166.x","article-title":"Impact of recently diagnosed multiple sclerosis on quality of life, anxiety, depression and distress of patients and partners","volume":"108","author":"Janssens","year":"2003","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.msard.2025.106309_bib0010","doi-asserted-by":"crossref","first-page":"145","DOI":"10.7224\/1537-2073.2017-069","article-title":"Somatic symptoms of depression and anxiety in people with Multiple sclerosis","volume":"20","author":"Jones","year":"2018","journal-title":"Int. J. MS Care"},{"key":"10.1016\/j.msard.2025.106309_bib0045","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/acps.12698","article-title":"Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies","volume":"135","author":"K\u00f6hler","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.msard.2025.106309_bib0017","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0306-4530(01)00068-3","article-title":"Expression of tumor necrosis factor-\u03b1 and interferon-\u03b3 mRNA in blood cells correlates with depression scores during an acute attack in patients with multiple sclerosis","volume":"27","author":"Kahl","year":"2002","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.msard.2025.106309_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2022.1068421","article-title":"The quality of life in patients with multiple sclerosis - association with depressive symptoms and physical disability: a prospective and observational study","volume":"13","author":"Ko\u0142tuniuk","year":"2023","journal-title":"Front. Psychol."},{"key":"10.1016\/j.msard.2025.106309_bib0049","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00004714-200104000-00012","article-title":"Anti-inflammatory effects of antidepressants through suppression of the interferon-gamma\/interleukin-10 production ratio","volume":"21","author":"Kubera","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.msard.2025.106309_bib0016","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0165-1781(94)90003-5","article-title":"Increased neopterin and interferon-gamma secretion and lower availability of l-tryptophan in major depression: further evidence for an immune response","volume":"54","author":"Maes","year":"1994","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.msard.2025.106309_bib0018","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.nbd.2017.07.019","article-title":"Interferon-\u03b3 causes mood abnormalities by altering cannabinoid CB1 receptor function in the mouse striatum","volume":"108","author":"Mandolesi","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.msard.2025.106309_bib0002","doi-asserted-by":"crossref","first-page":"e1316","DOI":"10.1212\/WNL.0000000000005302","article-title":"Psychiatric comorbidity is associated with disability progression in multiple sclerosis","volume":"90","author":"McKay","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106309_bib0011","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.3390\/ijms22094440","article-title":"Insights into the pathophysiology of psychiatric symptoms in Central nervous system disorders: implications for early and differential diagnosis","volume":"22","author":"Menculini","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msard.2025.106309_bib0009","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/jnnp-2022-329806","article-title":"Psychiatric symptoms in multiple sclerosis: a biological perspective on synaptic and network dysfunction","volume":"94","author":"Menculini","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2025.106309_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104431","article-title":"Clinical correlates of state and trait anxiety in multiple sclerosis","volume":"69","author":"Menculini","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106309_bib0015","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.194","article-title":"Absence of IFN\u03b3 promotes hippocampal plasticity and enhances cognitive performance","volume":"6","author":"Monteiro","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.msard.2025.106309_bib0003","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1176\/appi.neuropsych.15070167","article-title":"Anxiety and depressive symptoms are associated with worse performance on objective cognitive tests in MS","volume":"28","author":"Morrow","year":"2016","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.msard.2025.106309_bib0043","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/jamapsychiatry.2022.0645","article-title":"Cerebrospinal fluid biomarkers in patients with unipolar depression compared with healthy control individuals: a systematic review and meta-analysis","volume":"79","author":"Mousten","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.msard.2025.106309_bib0005","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/jnnp-2016-315367","article-title":"Neuropsychiatric syndromes of multiple sclerosis","volume":"88","author":"Murphy","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2025.106309_bib0048","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bbi.2013.04.003","article-title":"Tryptophan metabolism and immunogenetics in major depression: a role for interferon-\u03b3 gene","volume":"31","author":"Myint","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.msard.2025.106309_bib0047","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00702-010-0475-7","article-title":"Interferon-gamma-inducible kynurenines\/pteridines inflammation cascade: implications for aging and aging-associated psychiatric and medical disorders","volume":"118","author":"Oxenkrug","year":"2011","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.msard.2025.106309_bib0024","series-title":"Nuova Versione Italiana Dello S.T.A.I. \u2013 Forma Y","author":"Pedrabissi","year":"1989"},{"key":"10.1016\/j.msard.2025.106309_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102417","article-title":"Predictors of clinically significant anxiety in people with multiple sclerosis: a one-year follow-up study","volume":"45","author":"Podda","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106309_bib0006","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jpsychores.2012.09.011","article-title":"Suicide risk in multiple sclerosis: a systematic review of current literature","volume":"73","author":"Pompili","year":"2012","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.msard.2025.106309_bib0032","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1080\/13548506.2016.1274043","article-title":"The first year after diagnosis: psychological impact on people with multiple sclerosis","volume":"22","author":"Possa","year":"2017","journal-title":"Psychol. Health Med."},{"key":"10.1016\/j.msard.2025.106309_bib0014","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1212\/WNL.0000000000004411","article-title":"Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis","volume":"89","author":"Rossi","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106309_bib0021","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/ene.12932","article-title":"Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis","volume":"23","author":"Sacco","year":"2016","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2025.106309_bib0023","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/ane.12564","article-title":"Anxiety in Multiple sclerosis: psychometric properties of the State-trait Anxiety inventory","volume":"134","author":"Santangelo","year":"2016","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.msard.2025.106309_bib0004","doi-asserted-by":"crossref","first-page":"877","DOI":"10.30773\/pi.2019.0106","article-title":"Neuropsychiatric symptoms of multiple sclerosis: state of the art","volume":"16","author":"Silveira","year":"2019","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.msard.2025.106309_bib0012","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00415-019-09426-6","article-title":"Psychiatric disorders in multiple sclerosis","volume":"268","author":"Sparaco","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2025.106309_bib0025","series-title":"STAI Manual for the State-Trait Anxiety Inventory","author":"Spielberger","year":"1970"},{"key":"10.1016\/j.msard.2025.106309_bib0022","series-title":"Manual For the State-Trait Anxiety Inventory STAI (form Y) (\u2018self-evaluation questionnaire\u2019)","author":"Spielberger","year":"1983"},{"key":"10.1016\/j.msard.2025.106309_bib0026","article-title":"State-trait anxiety inventory","author":"Spielberger","year":"2010","journal-title":"Corsini Encyclopedia Psychol."},{"key":"10.1016\/j.msard.2025.106309_bib0007","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1590\/0004-282x20180036","article-title":"Suicidal ideation, anxiety, and depression in patients with multiple sclerosis","volume":"76","author":"Tauil","year":"2018","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.msard.2025.106309_bib0028","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181c47cc2","article-title":"A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking","volume":"73","author":"Teunissen","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106309_bib0019","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2025.106309_bib0044","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-019-0570-y","article-title":"Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses","volume":"9","author":"Yuan","year":"2019","journal-title":"Transl. Psychiatry"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825000537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825000537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T04:48:45Z","timestamp":1741841325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825000537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":53,"alternative-id":["S2211034825000537"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106309","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebrospinal fluid interferon-\u03b3 and development of depression in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106309","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106309"}}